Pure Global
NCT05264441

Choice of Inhalation Device

Choice of Inhalation Device in Asthma and COPD Patients
Universitair Ziekenhuis Brussel·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Asthma,COPD
Drug/Device/Intervention
In-Check DIAL G16
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Universitair Ziekenhuis Brussel
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2022
End date
Jun 01, 2023
Enrollment
140 participants
Primary outcome

Proportion of patients with device mismatch

Summary

In this study, asthma and COPD patients will be invited to participate after the consultation
 with their pulmonologist.
 
 The intervention consists of three steps. The first step is to perform a deep inspiration.
 The second step is to demonstrate the correct use of a pMDI. The third step is to perform a
 strong inspiration into the In-Check Dial device over 5 different resistances.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaOther chronic obstructive pulmonary disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05264441
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05264441 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitair Ziekenhuis Brussel and is currently Not yet recruiting. The study focuses on Asthma,COPD. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.